Preliminary results from a subset of patients (pts) with advanced ovarian cancer (OC) in a dose-escalation/expansion study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb)

T. Meniawy; G. Richardson; A. Townsend; J. Desai; Hui K. Gan; Michael Friedlander; L. Horvath; M. B. Jameson; S. Sandhu; Z. Wu; Z. Qin; K. Kang; B. Markman

Preliminary results from a subset of patients (pts) with advanced ovarian cancer (OC) in a dose-escalation/expansion study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb)

T. Meniawy, G. Richardson, A. Townsend, J. Desai, Hui K. Gan, Michael Friedlander, L. Horvath, M. B. Jameson, S. Sandhu, Z. Wu, Z. Qin, K. Kang, B. Markman

Research output: Contribution to journal › Abstract/Meeting Abstract

Original language	English
Number of pages	1
Journal	Annals of Oncology
Volume	28
Publication status	Published - Sep 2017
Externally published	Yes
Event	42nd European-Society-for-Medical-Oncology Congress (ESMO) - Madrid, Spain Duration: 8 Sep 2017 → 12 Sep 2017

Cite this

Meniawy, T., Richardson, G., Townsend, A., Desai, J., Gan, H. K., Friedlander, M., Horvath, L., Jameson, M. B., Sandhu, S., Wu, Z., Qin, Z., Kang, K., & Markman, B. (2017). Preliminary results from a subset of patients (pts) with advanced ovarian cancer (OC) in a dose-escalation/expansion study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb). Annals of Oncology, 28.

Meniawy, T. ; Richardson, G. ; Townsend, A. ; Desai, J. ; Gan, Hui K. ; Friedlander, Michael ; Horvath, L. ; Jameson, M. B. ; Sandhu, S. ; Wu, Z. ; Qin, Z. ; Kang, K. ; Markman, B. / Preliminary results from a subset of patients (pts) with advanced ovarian cancer (OC) in a dose-escalation/expansion study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb). In: Annals of Oncology. 2017 ; Vol. 28.

@article{3cd64a8d37db48bbbd254aed0e46cae5,

title = "Preliminary results from a subset of patients (pts) with advanced ovarian cancer (OC) in a dose-escalation/expansion study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb)",

author = "T. Meniawy and G. Richardson and A. Townsend and J. Desai and Gan, {Hui K.} and Michael Friedlander and L. Horvath and Jameson, {M. B.} and S. Sandhu and Z. Wu and Z. Qin and K. Kang and B. Markman",

year = "2017",

month = sep,

language = "English",

volume = "28",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

note = "42nd European-Society-for-Medical-Oncology Congress (ESMO) ; Conference date: 08-09-2017 Through 12-09-2017",

}

Preliminary results from a subset of patients (pts) with advanced ovarian cancer (OC) in a dose-escalation/expansion study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb). / Meniawy, T.; Richardson, G.; Townsend, A.; Desai, J.; Gan, Hui K.; Friedlander, Michael; Horvath, L.; Jameson, M. B.; Sandhu, S.; Wu, Z.; Qin, Z.; Kang, K.; Markman, B.

In: Annals of Oncology, Vol. 28, 09.2017.

Research output: Contribution to journal › Abstract/Meeting Abstract

TY - JOUR

T1 - Preliminary results from a subset of patients (pts) with advanced ovarian cancer (OC) in a dose-escalation/expansion study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb)

AU - Meniawy, T.

AU - Richardson, G.

AU - Townsend, A.

AU - Desai, J.

AU - Gan, Hui K.

AU - Friedlander, Michael

AU - Horvath, L.

AU - Jameson, M. B.

AU - Sandhu, S.

AU - Wu, Z.

AU - Qin, Z.

AU - Kang, K.

AU - Markman, B.

PY - 2017/9

Y1 - 2017/9

M3 - Abstract/Meeting Abstract

VL - 28

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

T2 - 42nd European-Society-for-Medical-Oncology Congress (ESMO)

Y2 - 8 September 2017 through 12 September 2017

ER -